Nuvation Bio Inc.

NYSE:NUVB

Biotechnology

Healthcare
$3.81 +1.03%

+$0.06 today

Market cap
$1.34B
Beta
1.56
P/E (TTM)
-12.8
EPS (TTM)
-$0.42
52W Low $1.81High $9.75

Volume 9.92M

Average 4.07M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$173.43M

FY 2025 · Annual

Investing Cash Flow

$99.52M

FY 2025 · Annual

-18.9% YoY

Financing Cash Flow

$202.53M

FY 2025 · Annual

+61088.8% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(86.85M)(104.2M)(75.8M)(567.94M)(204.63M)
Depreciation & Amortization184K199K222K683K1.74M
Deferred Income Tax00000
Stock-Based Compensation9.27M16.29M19.51M32.28M35.89M
Change in Working Capital4.79M(3.45M)540K(12.51M)(11.98M)
Accounts Receivables(1.95M)554K(1.22M)(12.59M)(3.07M)
Inventory0000(11.41M)
Accounts Payables1.86M(1.79M)70K(1.65M)3.13M
Other Working Capital4.88M(2.22M)1.69M1.74M(630K)
Other Non-Cash Items4.41M(4.95M)(12.47M)417.08M5.55M
Operating Cash Flow(68.19M)(96.11M)(68M)(130.41M)(173.43M)
Capital Expenditures(282K)(370K)(69K)(162K)(354K)
Acquisitions (Net)00012.43M0
Purchases of Investments(609.3M)(520.31M)(703.37M)(339.65M)(354.42M)
Sales of Investments154.91M584.12M712.35M450.08M462.29M
Other Investing Activities013K14K00
Investing Cash Flow(454.67M)63.46M8.92M122.7M99.52M
Debt Repayment000(4.55M)191.11M
Common Stock Issued0004.89M11.42M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities625.53M1.33M628K00
Financing Cash Flow625.53M1.33M628K331K202.54M
Effect of Forex Changes000453K(265K)
Net Change in Cash102.67M(31.32M)(58.45M)(6.93M)128.36M
Free Cash Flow(68.47M)(96.48M)(68.07M)(130.58M)(173.78M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$204.6M
+ D&A$1.7M
+ Stock-Based Comp$35.9M
+ Deferred Tax$0
- Working Capital-$12.0M
+ Other Non-Cash$5.5M
= Operating Cash Flow-$173.4M
- Capex-$354.0K
= Free Cash Flow-$173.8M

Analysis

FY2025 free cash flow is -$173.8M. FCF conversion is 84.9% of net income. Operating cash flow was -$173.4M, with capex of -$354.0K. The largest bridge item is Stock-Based Comp at $35.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
8-KCurrent reportAug 6, 2026
10-QQuarterly reportAug 6, 2026

Does NUVB generate free cash flow?

Nuvation Bio Inc. (NUVB) generated -$173.78M of free cash flow in fiscal 2025.

How much operating cash flow does NUVB produce?

Operating cash flow was -$173.43M, before capital expenditures of $354,000.00.